Innovative Medicines Initiative
Company Description
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
To know more, please visit www.imi.europa.eu.
Job of the week
EURACTIV News
- Commission wants to ease rules on use of processed manure for farming
- French Greens’ top candidate wants ‘European pharmaceutical sovereignty’
- Survey finds health is top concern for voters
- The Brief – The Gospel of Letta
- Commission changes view on controversial insecticide, set to propose zero residues in food
Agenda
18 Nov 2024
21 Oct 2024
15 Oct 2024
25 Jun 2024
17 Jun 2024
Subscribe to our jobletter!